Gilead to pay $97 million to settle U.S. kickback probe

Gilead Sciences Inchas agreed to pay $97 million (£76.3 million) to resolve U.S. government claims it used a purportedly independent charity to pay illegal kickbacks to cover Medicare patients' out-of-pocket costs for its pulmonary arterial hypertension drug Letairis.The U.S. Department of Justice said on Wednesday the settlement resolves allegations that Gilead improperly used the Caring Voice Coalition as a conduit to cover thousands of patients' co-payment obligations."Gilead used data